Swain Judith L
SEC CIK 1413573 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Dir | 174.5K | — | — | 5 | 2022-04-30 | 2026-06-03 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
| 14 | Swain Judith L | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-04 16:14 | 2026-06-03 | LXRX | LEXICON PHARMACEUTICALS, INC. | Swain Judith L | Dir | M - OptEx | $0.00 | +89.3K | 174.5K | +105% | $0 |
| D | 2025-05-13 | 2025-05-13 | LXRX | LEXICON PHARMACEUTICALS, INC. | Swain Judith L | Dir | M - OptEx | $0.00 | +36.8K | 85.2K | +76% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Swain Judith L | Dir | M - OptEx | $0.00 | +8,032 | 48.4K | +20% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | LEXICON PHARMACEUTICALS, INC. | Swain Judith L | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2022-05-02 | 2022-04-30 | LXRX | LEXICON PHARMACEUTICALS, INC. | Swain Judith L | Dir | M - OptEx | $0.00 | +4,024 | 31.0K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations